Switch from etravirine twice daily to once daily in non-nucleoside reverse transcriptase inhibitor (NNRTI)-resistant HIV-infected patients with suppressed viremia: the Monetra study.
about
Etravirine as a Switching Option for Patients with HIV RNA Suppression: A Review of Recent Trials.Etravirine for the treatment of HIV/AIDS.Design of novel leads: ligand based computational modeling studies on non-nucleoside reverse transcriptase inhibitors (NNRTIs) of HIV-1.Pharmacokinetics and pharmacodynamics of etravirine 400 mg once daily in treatment-naïve patients.
P2860
Switch from etravirine twice daily to once daily in non-nucleoside reverse transcriptase inhibitor (NNRTI)-resistant HIV-infected patients with suppressed viremia: the Monetra study.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Switch from etravirine twice d ...... ed viremia: the Monetra study.
@en
Switch from etravirine twice d ...... everse transcriptase inhibitor
@nl
type
label
Switch from etravirine twice d ...... ed viremia: the Monetra study.
@en
Switch from etravirine twice d ...... everse transcriptase inhibitor
@nl
prefLabel
Switch from etravirine twice d ...... ed viremia: the Monetra study.
@en
Switch from etravirine twice d ...... everse transcriptase inhibitor
@nl
P2093
P2860
P356
P1433
P1476
Switch from etravirine twice d ...... ed viremia: the Monetra study.
@en
P2093
G Peytavin
L Assoumou
L Schneider
P2860
P304
P356
10.1310/HCT1305-284
P577
2012-09-01T00:00:00Z